Guilin Sanjin Pharmaceutical Co Ltd Tangible Net Worth Ratio
Guilin Sanjin Pharmaceutical Co Ltd tangible net worth ratio. Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Tangible Net Worth Ratio of 95.8% as of September 2025. This metric is calculated by deducting intangible assets (CN¥136.39 Million) from net assets (CN¥3.24 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 002275 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Tangible net worth ratio of Guilin Sanjin Pharmaceutical Co Ltd from 2006 to 2024. This chart shows how Guilin Sanjin Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 19 annual periods from 2006 to 2024. As of September 2025, the ratio stands at 95.8%, reflecting net assets of CN¥3.24 Billion with intangible assets of CN¥136.39 Million CNY. Check 002275 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Guilin Sanjin Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2006–2024)
Guilin Sanjin Pharmaceutical Co Ltd tangible net worth ratio by year from 2006 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Guilin Sanjin Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of Guilin Sanjin Pharmaceutical Co Ltd.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 95.3% | CN¥3.01 Billion | CN¥141.55 Million | CN¥4.23 Billion | ▲ +0.7 pp |
| 2023 | 94.5% | CN¥2.82 Billion | CN¥153.56 Million | CN¥3.94 Billion | ▲ +0.5 pp |
| 2022 | 94.0% | CN¥2.81 Billion | CN¥168.28 Million | CN¥3.96 Billion | ▲ +0.3 pp |
| 2021 | 93.7% | CN¥2.84 Billion | CN¥178.36 Million | CN¥4.10 Billion | ▼ -0.4 pp |
| 2020 | 94.1% | CN¥2.96 Billion | CN¥174.55 Million | CN¥3.88 Billion | ▲ +0.3 pp |
| 2019 | 93.8% | CN¥2.82 Billion | CN¥174.23 Million | CN¥3.42 Billion | ▲ +0.1 pp |
| 2018 | 93.7% | CN¥2.81 Billion | CN¥176.22 Million | CN¥3.41 Billion | ▲ +0.2 pp |
| 2017 | 93.5% | CN¥2.65 Billion | CN¥172.70 Million | CN¥3.23 Billion | ▲ +0.9 pp |
| 2016 | 92.6% | CN¥2.43 Billion | CN¥180.57 Million | CN¥2.87 Billion | ▼ -0.1 pp |
| 2015 | 92.7% | CN¥2.34 Billion | CN¥171.95 Million | CN¥2.76 Billion | ▲ +0.4 pp |
| 2014 | 92.3% | CN¥2.32 Billion | CN¥179.37 Million | CN¥2.78 Billion | ▲ +0.8 pp |
| 2013 | 91.5% | CN¥2.20 Billion | CN¥187.52 Million | CN¥2.69 Billion | ▼ -0.4 pp |
| 2012 | 91.9% | CN¥2.08 Billion | CN¥168.17 Million | CN¥2.49 Billion | ▼ -0.3 pp |
| 2011 | 92.2% | CN¥1.98 Billion | CN¥154.10 Million | CN¥2.20 Billion | ▲ +1.0 pp |
| 2010 | 91.2% | CN¥1.80 Billion | CN¥158.46 Million | CN¥1.98 Billion | ▼ -7.2 pp |
| 2009 | 98.4% | CN¥1.78 Billion | CN¥27.94 Million | CN¥2.06 Billion | ▲ +5.1 pp |
| 2008 | 93.4% | CN¥787.10 Million | CN¥52.21 Million | CN¥1.17 Billion | ▼ -2.9 pp |
| 2007 | 96.2% | CN¥729.25 Million | CN¥27.38 Million | CN¥1.08 Billion | ▲ +0.9 pp |
| 2006 | 95.3% | CN¥627.33 Million | CN¥29.24 Million | CN¥831.81 Million | — |